Childhood obesity is a significant health concern in the US and worldwide. How does obesity impact a child's cardiovascular function and influence future risk of heart disease? Dr. Nathalie Farpour-Lambert, head of the Pediatric Exercise Medicine and Obesity Care Program in the department of pediatrics at the University Hospitals of Geneva in Switzerland, discusses new findings about the effect of a modest amount of physical activity in improving blood pressure, arterial function and arterial wall thickness in obese children. How can clinicians overcome the biggest challenges in encouraging a healthy lifestyle for their pediatric patients?
A Global Issue: Obesity and Improving Cardiovascular Health in Children

Ready to Claim Your Credits?
You have attempts to pass this post-test. Take your time and review carefully before submitting.
Good luck!
Overview
Childhood obesity is a significant health concern in the US and worldwide. How does obesity impact a child's cardiovascular function and influence future risk of heart disease? Dr. Nathalie Farpour-Lambert, head of the Pediatric Exercise Medicine and Obesity Care Program in the department of pediatrics at the University Hospitals of Geneva in Switzerland, discusses new findings about the effect of a modest amount of physical activity in improving blood pressure, arterial function and arterial wall thickness in obese children. How can clinicians overcome the biggest challenges in encouraging a healthy lifestyle for their pediatric patients?
Produced in Cooperation with
Title
Share on ReachMD
CloseProgram Chapters
Segment Chapters
Playlist:
Recommended
Implementing a Multidisciplinary Approach to Heart Failure: Patient Identification and Treatment Using Novel Device Therapy
Phase 3 study results of plozasiran in patients with FCS
Advances in MASLD/MASH: Treating the Liver, the Disease, and the Patient – Chair’s Perspective
IgG4-RD Case Conversations: The Peculiarities of Kidney Involvement
IgG4-RD Case Conversations: Using Thoracic CT as a Diagnostic Clue
IgG4-RD Case Conversations: Diagnosing Pancreaticobiliary Manifestations and Ruling Out Malignancy
HF Management for Patients with Comorbid Conditions
FAIR-HF2 Trial: Ferric Carboxymaltose Assessment of Morbidity and Mortality in Patients with Iron Deficiency and Chronic Heart Failure
We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?